Thursday, 31 May 2018

Utah sues opioid maker Purdue Pharma after settlement talks stall

(Reuters) - Utah's attorney general on Thursday sued OxyContin maker Purdue Pharma LP to hold it responsible for its role in the opioid epidemic after he said talks to reach a settlement between various states and the drugmaker stopped being productive.


DACA program tied to health of U.S.-citizen kids

(Reuters Health) - The U.S. Deferred Action for Childhood Arrivals program, known as DACA, has spillover benefits for the health of the young children of DACA-eligible mothers, a recent study suggests.


Madrigal Pharma more than doubles after liver drug study success

(Reuters) - Madrigal Pharmaceuticals Inc's shares more than doubled after mid-stage trial data showed its lead drug reduced liver fat in patients with fatty liver disease, placing it ahead of larger rivals to tap into a potential market worth $30 billion.


Madrigal Pharma's liver drug succeeds in study, shares soar

(Reuters) - Madrigal Pharmaceuticals Inc's lead experimental drug achieved the main goal of reducing liver fat in patients with fatty liver disease in a mid-stage study, sending its shares surging 66 percent in premarket trading on Thursday.


U.S. voices concern over increasingly deadly Bangladeshi anti-drug drive

DHAKA (Reuters) - The United States has expressed concern about a Bangladeshi anti-drugs campaign in which more than 100 people have died but the government has dismissed any suggestion of extra-judicial killings and said the crackdown had popular support.


Madrigal Pharma's liver disease drug succeeds in study, shares soar

(Reuters) - Madrigal Pharmaceuticals Inc said on Thursday its lead experimental drug achieved the main goal of reducing liver fat in patients with a type of liver disease in a mid-stage study, sending its shares surging 40 percent in premarket trading.


Another antibiotic crisis: fragile supply leads to shortages

LONDON (Reuters) - Shortages of some life-saving antibiotics are putting growing numbers of patients at risk and fuelling the evolution of "superbugs" that do not respond to modern medicines, according to a new report on Thursday.


France's Lactalis tests plant after tainted milk scandal

PARIS (Reuters) - Lactalis is testing production at its Craon plant in northwest France that had been halted because dozens of babies were found ill last year after drinking salmonella-contaminated milk produced at the factory, the company said on Thursday.


Madrigal Pharma's liver disease drug succeeds in mid-stage trial

(Reuters) - Madrigal Pharmaceuticals Inc said on Thursday a mid-stage trial testing its lead experimental treatment for a liver disease achieved the main goal of reducing liver fat.


African Swine Fever outbreak reported in South Africa

JOHANNESBURG (Reuters) - African Swine Fever (ASF), a severe hemorrhagic disease of pigs, has been reported in South Africa's Northern Cape Province, the department of agriculture said on Thursday.


African Swine Fever outbreak reported in South Africa: agriculture dept

JOHANNESBURG (Reuters) - African Swine Fever, a severe hemorrhagic disease of pigs, has been reported in South Africa's Northern Cape Province, the department of agriculture said on Thursday.


Wednesday, 30 May 2018

American Cancer Society recommends earlier colorectal cancer screening

(Reuters) - The American Cancer Society is recommending that people at average risk of colorectal cancer start regular screening at age 45 rather than at 50, at a time when studies show a rise in cases of the disease among younger individuals.


Trump: major drug companies to announce voluntary price cuts soon

WASHINGTON (Reuters) - President Donald Trump on Wednesday said he expects major drug companies to cut prices on their products, but did not provide details.